NEW YORK (GenomeWeb News) – Ion Torrent Systems has extended the deadline to apply for its Ion Personal Genome Machine Sequencer grant program from April 4 to April 18.
Under the program, the company plans to give away two of its sequencers to scientists proposing projects that take best advantage of the instrument's speed, ease of use, small footprint, and low cost per run.
Ion Torrent said it is extending the deadline "to accommodate the large number of applications the company is receiving."
BioReference Laboratories said that its board of directors has approved a two-for-one split of its stock.
As of the close of business on April 19, each holder of BRLI common stock will receive one additional share for each share owned.
Distribution of the additional shares is expected to be made on or about April 21.
Consumables manufacturer Phenomenex said this week that it is now marketing its products in Mexico directly, as opposed to through distributors.
Customers in Mexico will now be able to purchase products directly through the firm and will have access to faster product delivery, technical support in Spanish, training, and seminars, the company said.
IntegenX (formerly Microchip Biotechnologies) has opened its new corporate headquarters and manufacturing facility in the Hacienda Business Park in Pleasanton, Calif.
The company was previously located in Dublin, Calif.
The new facility includes a microfabrication facility, custom-designed laboratories, and manufacturing space for commercial operations.
IntegenX manufactures automated DNA and RNA-based sample-preparation systems for life sciences, applied sciences, and diagnostics markets.
Kreatech Diagnostics said that it is now providing direct support for its Universal Linkage System products in North America.
The Dutch firm said that it has established "a direct point of contact" in the San Francisco Bay Area and provides direct coverage across North America.
Kreatech’s ULS technology is based on platinum, which the company said offers stable binding properties that offer "significant advantages" over traditional labeling techniques.
TriLink BioTechnologies has tapped Cedarlane, a Canadian research biotechnology company, to distribute its modified nucleoside triphosphates, custom chemistry, and oligonucleotide products in Canada and the Northern US.
Cedarlane currently provides research products to more than 25,000 scientists, "making TriLink's custom nucleotides and oligonucleotides more accessible internationally to the biomedical market," the company said.